LAUSR

Abstract Metal‐induced hypersensitivity is driven by T‐cell sensitization to metal ions. Although numerous metals are associated with the development of diffuse parenchymal lung disease, beryllium‐induced hypersensitivity is the best‐studied to date. This review focuses on the interaction between innate and adaptive immunity that leads to the development of chronic beryllium disease. After beryllium exposure, activation of the innate immune system occurs through the engagement of pattern‐recognition receptors. This activation leads to cell death, release of alarmins, and activation and migration of dendritic cells to lung‐draining lymph nodes. These events culminate in the development of an adaptive immune response that is characterized by beryllium‐specific, T‐helper type 1‐polarized, CD4+ T‐cells and granuloma formation in the lung. The unique ability of beryllium to bind to human leukocyte antigen‐DP molecules that express a glutamic acid at position 69 of the &bgr;‐chain alters the charge and conformation of the human leukocyte antigen‐DP‐peptide complex. These changes induce post‐translational modifications that are recognized as non‐self. In essence, the ability of beryllium to create neoantigens underlies the genesis of chronic beryllium disease, and demonstrates the similarity between beryllium‐induced hypersensitivity and autoimmunity.